Tuesday, September 15, 2026

Rodong Sinmun’s Language Signals Cautious Posture Toward Trump Administration

North Korean media shows a respectful tone towards Trump, hinting at a special bond, contrasting previous harsh rhetoric.

South Korea and Japan in Talks of Bilateral Summit in Washington D.C.

It was reported that President Yoon Suk...

As South Korea Launches Integrated Care, Doctors Warn the System Isn’t Ready

The Korean Medical Association raises concerns about the implementation of "Integrated Care," citing infrastructure and compensation issues.

Tag: market

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

Yuhan Corp., Celltrion and LigaChem Bio…K-Pharma Firms Move to Boost Corporate Value

The pharmaceutical and biotech sectors are boosting shareholder trust and corporate value through stock buybacks and retirements.

Unlocking AI Potential: How 3D NAND and zHBM Are Revolutionizing Memory Technology

Memory semiconductor competition is expanding from HBM-based DRAM to NAND flash to meet rising AI data center demand.

SkyLabs’ CART BP Pro: The Revolutionary Ring-Style Blood Pressure Monitor Set to Gain FDA Approval in 2027

Skylabs accelerates its U.S. market entry by starting clinical trials for its ring-shaped blood pressure monitor, seeking FDA approval.

Celltrion expands U.S. PBM coverage, boosting outlook for high-margin biosimilars

Celltrion expands its listing with US PBM, enhancing its high-profit biosimilar product base and boosting sales expectations for H2.

More Than Half of Galaxy Z8 Preorders Come From Younger Buyers, With Cream Emerging as the Most Popular Color

Samsung's Galaxy Z Fold 8 and Flip 8 are gaining popularity among the 10-30 age group during pre-sales.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

HLB PEP Achieves FDA Registration for Vasopressin API: What This Means for Global Markets

HLB PEP has registered Vasopressin API with the FDA, aiming for global market entry and expanding its peptide portfolio.

Samsung Biologics’ Q2 Success: 30% Revenue Growth and Global Expansion Plans

Samsung Biologics exceeded Q2 market expectations due to stable performance from existing plants and new facilities in the U.S.

Kia Sportage Triumphs: 2026’s Top Compact SUV in Europe – What Makes It Stand Out?

Kia's Sportage excels in a German SUV comparison, topping evaluations in multiple categories and showcasing strong sales in Europe.

Samsung Galaxy Card: Unlock 200 USD Bonus Rewards with New Credit Card Launch in the U.S.

Samsung introduces the Galaxy Card in the U.S., offering cashback rewards and discounts, enhancing user experience through Samsung Wallet integration.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

How Celltrion’s Omlyclo Achieved 16% Market Share in Europe: A Game-Changer for Biologics

Celltrion's biosimilars gain market share in Europe, with Omlyclo leading in Spain and Vegzelma maintaining strong presence amid competition.

Samsung’s AI PC Chip Gaia: What to Expect from 2027’s Cutting-Edge Technology?

Samsung Electronics is developing AI chips for PCs, aiming for mass production next year, marking its return to the PC chip market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.